[Correlation between thrombolytic therapy and liver rupture?].
D000328:Adult; D001780:Blood Coagulation Tests; D056486:Chemical and Drug Induced Liver Injury; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D019304:Ethinyl Estradiol-Norgestrel Combination; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D009644:Norgestrel / Q000009:adverse effects*; D012422:Rupture, Spontaneous; D013300:Streptokinase / Q000009:adverse effects* / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000139:chemically induced / Q000188:drug therapy*
D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D005343:Fibrinolytic Agents; D009644:Norgestrel; D004997:Ethinyl Estradiol; D019304:Ethinyl Estradiol-Norgestrel Combination; D013300:Streptokinase
Zusammenhang zwischen Thrombolysetherapie und Leberruptur?